| symbol | subject | date & time | rating |
|
|
if it only made under 4m in revenue in 2012 and is worth 14m on the balance sheet, then why is it trading at a market cap of 312 m. |
6/12/2013 4:11:38 PM |
|
|
|
The Company has also issued a total of 1,151,647 new incentive stock options to officers, directors and employees exercisable at a price of $0.40 with an expiry date of May 31, 2023. The stock options shall only be exercisable following two conse... |
6/11/2013 6:25:56 AM |
|
|
|
http://www.mineweb.com/mineweb/content/en/mineweb-silver-news?oid=168376&sn=Detail |
6/11/2013 6:14:44 AM |
4 |
|
|
Check SSS, CEO is from old cancer company YM sold for 500m to Gilead. they got a cancer drug in phase 2b starting 2014. Researcher won an award from cancer institute. do your own DD. I doubt partnerships occur in clinical phase and if they do j... |
6/11/2013 4:45:57 AM |
|
|
|
look at the bond holders dumping the last month alone, this is in trouble if they dont raise the money, sure they can get a contract with cn rail, how are they going to buy the shovels and dump trucks?? look at adanac moly in recievership after i... |
6/6/2013 10:13:09 AM |
3 |
|
|
http://www.tmx.com/en/news_events/exchange_bulletins/bulletins/4-26-2013_TSX-ReviewCMK.html |
6/6/2013 9:56:03 AM |
3 |
|
|
it shows their operating profit in their income statement for 2012 as -1,599,000, then if they get a +500,000 injection and +1,500,000 standy by credit extension, offered by Doughty Hansen, then perhaps they are using this to purchase the equipme... |
6/5/2013 3:41:18 AM |
4 |
|
|
Where do you come up with all you material??? paragraphs and paragraphs of nonsense and garbage. If you read the website or news it says the German government is providing incentives for solar. The Germans are against nuclear thats for sure. An... |
6/4/2013 2:27:10 PM |
|
|
|
625 m shares outstanding, no mine no revenue, wonder how the bond holders are going to raise money.... on days like this? |
6/4/2013 1:56:39 PM |
2 |
|
|
Erinn B. Broshko, MBI's Executive Chairman noted: "The exercise of these warrants strengthens MBI's balance sheet and is meaningful given our focused and efficient burn rate. Moreover, it is a vote of confidence by our shareholders i... |
6/2/2013 8:16:51 PM |
|
|
12/12/2012 1:49:32 PM
| 150 reads
| overall quality: 3
Gilead Sciences to Buy YM BioSciences for $510 Million http://ca.finance.yahoo.com/q?s=YM.TO%2C+&ql=0 http://www.bloomberg.com/news/2012-12-12/gilead-sciences-to-buy-ym-biosciences-for-510-million.html?cmpid=yhoo Gilead Sciences Inc. (GILD), ...
11/10/2012 4:10:06 PM
| 528 reads
| overall quality: 3
http://www.genengnews.com/gen-news-highlights/new-emd-millipore-reportedly-the-third-largest-investor-in-life-science-tools-r-d/81243672/ Merck KGaA successful completed its $7 billion acquisition of Millipore yesterday and created the new EM...
9/4/2012 5:57:51 AM
| 169 reads
| overall quality: 4
Canada's Valeant Pharmaceuticals agrees to buy rival Medicis for about $2.6B http://www.canadianbusiness.com/article/97267--pharmaceutical-takeover-montreal-based-valeant-to-buy-arizona-s-medicisNEW YORK, N.Y. - Valeant Pharmaceuticals Intern...
8/12/2012 3:34:19 PM
| 313 reads
| overall quality: 4
Biotech M&A at 4-year high as pharma faces expiring patents http://www.reuters.com/article/2012/08/02/us-healthcare-deals-idUSBRE8711H420120802 Global biotech merger volume has reached levels not seen in four years as big pharmaceutical compa...
Stockhouse.com: Taking
it to the street
